JP2008517922A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517922A5
JP2008517922A5 JP2007538050A JP2007538050A JP2008517922A5 JP 2008517922 A5 JP2008517922 A5 JP 2008517922A5 JP 2007538050 A JP2007538050 A JP 2007538050A JP 2007538050 A JP2007538050 A JP 2007538050A JP 2008517922 A5 JP2008517922 A5 JP 2008517922A5
Authority
JP
Japan
Prior art keywords
number pta
designation number
patent deposit
deposit designation
atcc patent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007538050A
Other languages
English (en)
Japanese (ja)
Other versions
JP4898691B2 (ja
JP2008517922A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/037821 external-priority patent/WO2006047249A1/en
Publication of JP2008517922A publication Critical patent/JP2008517922A/ja
Publication of JP2008517922A5 publication Critical patent/JP2008517922A5/ja
Application granted granted Critical
Publication of JP4898691B2 publication Critical patent/JP4898691B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007538050A 2004-10-22 2005-10-21 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法 Expired - Fee Related JP4898691B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62155304P 2004-10-22 2004-10-22
US60/621,553 2004-10-22
PCT/US2005/037821 WO2006047249A1 (en) 2004-10-22 2005-10-21 Anti-il-22ra antibodies and binding partners and methods of using in inflammation

Publications (3)

Publication Number Publication Date
JP2008517922A JP2008517922A (ja) 2008-05-29
JP2008517922A5 true JP2008517922A5 (enExample) 2011-09-22
JP4898691B2 JP4898691B2 (ja) 2012-03-21

Family

ID=35871017

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538050A Expired - Fee Related JP4898691B2 (ja) 2004-10-22 2005-10-21 抗ｉｌ−２２ｒａ抗体および結合パートナー、ならびに炎症における使用法

Country Status (21)

Country Link
US (5) US7537761B2 (enExample)
EP (1) EP1812476B1 (enExample)
JP (1) JP4898691B2 (enExample)
KR (1) KR101238684B1 (enExample)
CN (1) CN101198625A (enExample)
AT (1) ATE474856T1 (enExample)
AU (1) AU2005299809B2 (enExample)
BR (1) BRPI0516975A (enExample)
CA (1) CA2584157C (enExample)
CY (1) CY1110843T1 (enExample)
DE (1) DE602005022475D1 (enExample)
DK (1) DK1812476T3 (enExample)
EA (1) EA015706B1 (enExample)
ES (1) ES2347672T3 (enExample)
IL (2) IL182503A (enExample)
MX (1) MX2007004770A (enExample)
NO (1) NO20072602L (enExample)
PT (1) PT1812476E (enExample)
UA (1) UA96122C2 (enExample)
WO (1) WO2006047249A1 (enExample)
ZA (1) ZA200704125B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
WO2002012345A2 (en) * 2000-08-08 2002-02-14 Zymogenetics, Inc. Soluble zcytor 11 cytokine receptors
MXPA05010134A (es) * 2003-03-24 2005-11-16 Zymogenetics Inc Anticuerpos anti-il-20, metodos y moleculas de enlace que se usan en la inflamacion.
JP4991307B2 (ja) * 2003-11-21 2012-08-01 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
US7537761B2 (en) * 2004-10-22 2009-05-26 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
EP1954719A2 (en) * 2005-12-02 2008-08-13 Genentech Inc. Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
WO2011047153A1 (en) * 2009-10-15 2011-04-21 President And Fellows Of Harvard College Methods for modulating autoimmunity
PH12012500924A1 (en) 2009-11-19 2012-11-26 Merck Serono Sa Humanized antibodies against human il-22ra
WO2011104381A2 (en) 2010-02-26 2011-09-01 Novo Nordisk A/S Stable antibody containing compositions
CA2800188A1 (en) 2010-05-28 2011-12-01 Novo Nordisk A/S Stable multi-dose compositions comprising an antibody and a preservative
AU2012204574B2 (en) 2011-01-04 2017-05-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating age-related macular degeneration
CA2828753C (en) 2011-03-16 2022-07-26 arGEN-X BV Antibodies to cd70
US8603470B1 (en) 2012-08-07 2013-12-10 National Cheng Kung University Use of IL-20 antagonists for treating liver diseases
US10391168B1 (en) 2014-08-22 2019-08-27 University Of Bern Anti-CD70 combination therapy
EP3442562B1 (en) * 2016-04-15 2022-09-21 Evive Biotechnology (Shanghai) Ltd An il-22 dimer for use in treating necrotizing enterocolitis
EP3464357A1 (en) 2016-05-24 2019-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections
GB201612337D0 (en) 2016-07-15 2016-08-31 Argen-X N V Ant-il-22r antibodies
WO2018097646A1 (ko) * 2016-11-24 2018-05-31 이형근 질환의 진단용 조성물
GB201800649D0 (en) 2018-01-16 2018-02-28 Argenx Bvba CD70 Combination Therapy
WO2019236585A1 (en) 2018-06-05 2019-12-12 Bioatla, Llc Anti-il-22 antibodies, antibody fragments, their immunoconjugates and uses thereof
CN110078832B (zh) * 2019-04-18 2021-12-14 江南大学 一类基于ZZ domain的二抗及其制备方法和应用
CN117425674A (zh) * 2021-03-02 2024-01-19 丹娜法伯癌症研究院 治疗红细胞疾患的方法
WO2024184333A1 (en) 2023-03-08 2024-09-12 Leo Pharma A/S Il-22r antibody for use in treating atopic dermatitis

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654090A (en) * 1968-09-24 1972-04-04 Organon Method for the determination of antigens and antibodies
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
EP0154316B1 (en) 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
NZ212437A (en) 1985-06-17 1992-06-25 Mark Philip Best Site-directed antibody conjugates, and their preparation
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5567584A (en) 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5116964A (en) 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US5436155A (en) 1991-12-31 1995-07-25 Arch Development Corporation Isolated DNA encoding a somatostatin receptor
US5789192A (en) 1992-12-10 1998-08-04 Schering Corporation Mammalian receptors for interleukin-10 (IL-10)
DE69740038D1 (enExample) 1996-07-12 2010-12-16 Genentech Inc
US5843697A (en) 1996-07-17 1998-12-01 University Of Medicine And Dentistry Of New Jersey Cells expressing IL-10 receptor and the CRFB4 gene product, an IL-10 receptor accessory protein
US5985614A (en) 1996-08-30 1999-11-16 Human Genome Sciences, Inc. Polynucleotides encoding interleukin-19
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
US6133426A (en) 1997-02-21 2000-10-17 Genentech, Inc. Humanized anti-IL-8 monoclonal antibodies
EP1012260A4 (en) 1997-07-16 2001-05-09 Human Genome Sciences Inc INTERLEUKINE-20
US6486301B1 (en) 1997-07-16 2002-11-26 Human Genome Sciences, Inc. Interleukin-20
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
US6020163A (en) 1997-08-06 2000-02-01 Zymogenetics, Inc. Lipocalin homolog
US6551799B2 (en) 1999-12-07 2003-04-22 Genentech, Inc. Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
CN1618969A (zh) 1997-11-26 2005-05-25 津莫吉尼蒂克斯公司 哺乳动物细胞因子样多肽－10
US6576743B1 (en) 1997-11-26 2003-06-10 Zymogenetics, Inc. Mammalian cytokine-like polypeptide-10
PT1047781E (pt) 1998-01-23 2004-11-30 Immunex Corp Receptores de il-18
EP1062332A2 (en) 1998-03-09 2000-12-27 Schering Corporation Human receptor proteins; related reagents and methods
DK1490386T3 (da) 1998-03-10 2008-12-15 Genentech Inc Nyt polypeptid og nukleinsyrer kodende for dette
US6197582B1 (en) 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US6982320B2 (en) 1998-03-19 2006-01-03 Human Genome Sciences, Inc. Cytokine receptor common gamma chain like
WO1999061630A2 (en) 1998-05-26 1999-12-02 Regeneron Pharmaceuticals, Inc. Chimeric molecules comprising an extracellular ligand binding domain of a receptor and an ige fc or constant region, and their use in an assay system
ATE251181T1 (de) 1998-07-28 2003-10-15 Micromet Ag Heterominikörper
NZ510464A (en) 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
US6472179B2 (en) 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6331613B1 (en) 1998-10-26 2001-12-18 Ludwig Institue For Cancer Research Isolated nucleic acid molecules which encode T cell inducible factors (TIFS), the proteins encoded, and uses thereof
US6274710B1 (en) 1998-10-26 2001-08-14 Ludwig Institute For Cancer Research Antibodies which specifically bind T Cell inducible factors (TIFs)
AU2222700A (en) 1998-12-31 2000-07-31 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them
WO2000065027A2 (en) 1999-04-28 2000-11-02 Genetics Institute, Inc. Human gil-19/ae289 proteins and polynucleotides encoding same
CA2373231A1 (en) 1999-05-19 2000-11-23 Incyte Genomics, Inc. Extracellular signaling molecules
WO2000073457A1 (en) 1999-05-27 2000-12-07 Schering-Corporation Mammalian interleukin-10 homologs: il-d110 and il-d210
CA2372511C (en) 1999-06-15 2011-11-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2883700A (en) 1999-06-23 2001-01-09 Genentech Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2378519C (en) 1999-07-07 2011-01-25 Zymogenetics, Inc. Human cytokine receptor
EP1208202A2 (en) 1999-09-01 2002-05-29 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU1919201A (en) 1999-11-18 2001-05-30 Schering Corporation Mammalian receptor proteins; related reagents and methods
US6897292B2 (en) 1999-12-03 2005-05-24 Zymogenetics, Inc. Human cytokine receptor
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
CA2395539C (en) 1999-12-23 2009-08-25 Zymogenetics, Inc. Soluble interleukin-20 receptor
ATE459716T1 (de) 1999-12-23 2010-03-15 Zymogenetics Inc Zytokin zcyt018
ATE459369T1 (de) 1999-12-23 2010-03-15 Zymogenetics Inc Verfahren zur behandlung von entzündungen
NZ523122A (en) 2000-06-22 2004-06-25 Smithkline Beecham Corp Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
JP2002015498A (ja) 2000-06-29 2002-01-18 Fujitsu Ltd センス電流の設定方法
WO2002012345A2 (en) 2000-08-08 2002-02-14 Zymogenetics, Inc. Soluble zcytor 11 cytokine receptors
EP2298789B1 (en) 2000-09-08 2012-03-14 Schering Corporation Mammalian genes; related reagents and methods
ES2267814T3 (es) 2000-09-15 2007-03-16 Zymogenetics, Inc. Metodo para tratar la inflamacion.
US7268223B2 (en) 2000-09-22 2007-09-11 Wyeth Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof
EP1191035A3 (de) 2000-09-25 2002-04-17 Schering Aktiengesellschaft Drei Mitglieder der Zytokinrezeptorfamilie Klasse II
US20030022827A1 (en) 2000-09-25 2003-01-30 Bertram Weiss Three new members of the cytokine receptor family class 2
JP2004533811A (ja) 2001-01-12 2004-11-11 ジェネティクス インスティテュート，エルエルシー ２型サイトカインレセプターおよび２型サイトカインレセプターをコードする核酸
EP1390060A2 (en) 2001-01-26 2004-02-25 Eli Lilly And Company Use of lp82 to treat body weight disorders
NZ527396A (en) 2001-02-23 2007-12-21 Genetics Inst Llc Antibodies and fragments thereof for the binding of IL-22 and use therefore for treating inflammatory disorders
CA2433933A1 (en) 2001-02-28 2002-09-12 Eli Lilly And Company Use of lp82 to treat hematopoietic disorders
JP2004532624A (ja) 2001-03-02 2004-10-28 ザイモジェネティクス，インコーポレイティド マウスサイトカイン受容体
AU2002245652A1 (en) * 2001-03-09 2002-09-24 Zymogenetics, Inc. Soluble heterodimeric cytokine receptor
US20040086908A1 (en) * 2002-03-07 2004-05-06 Chandrasekher Yasmin A. Soluble heterodimeric cytokine receptor
WO2002077174A2 (en) 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
PT1392359E (pt) 2001-05-11 2010-01-27 Ludwig Inst For Cancer Res Ltd Proteínas de ligação específica e suas utilizações
EP1439850A4 (en) 2001-10-22 2006-05-03 Lilly Co Eli SOLUBLE PROTEINS THAT RESIST CYTOKIN SIGNAL TRANSFER PATHS
DE10154579A1 (de) 2001-11-07 2003-05-28 Medigene Ag Topikale Verwendung von Cytokinen und Chemokinen zur Behandlung von viralen oder mykotischen Hauterkrankungen oder Tumorerkrankungen
IL161978A0 (en) 2001-12-17 2005-11-20 Zymogenetics Inc Method for treating cervical cancer
US20040236075A1 (en) * 2002-07-24 2004-11-25 Laure Dumoutier Novel glass II cytokine receptors, and uses thereof
MXPA05010134A (es) * 2003-03-24 2005-11-16 Zymogenetics Inc Anticuerpos anti-il-20, metodos y moleculas de enlace que se usan en la inflamacion.
JP4991307B2 (ja) 2003-11-21 2012-08-01 ザイモジェネティクス， インコーポレイテッド 抗ｉｌ−２０抗体および結合パートナーならびに炎症において用いる方法
US7537761B2 (en) * 2004-10-22 2009-05-26 Zymogenetics, Inc. Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
PH12012500924A1 (en) * 2009-11-19 2012-11-26 Merck Serono Sa Humanized antibodies against human il-22ra

Similar Documents

Publication Publication Date Title
JP2008517922A5 (enExample)
KR102321172B1 (ko) 염증성 질환에서 il-18 결합 단백질(ｉｌ-18ｂｐ)
Nocker et al. lnterleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease
Nonaka et al. Distinct immunohistochemical localization of IL-4 in human inflamed airway tissues. IL-4 is localized to eosinophils in vivo and is released by peripheral blood eosinophils.
Raqib et al. Persistence of local cytokine production in shigellosis in acute and convalescent stages
DE69933115T2 (de) Verwendung eines antagonisten antikörpers gegen den entzündungsmediator oncostatin m (osm)
JP4927762B2 (ja) Ｉｌ−３１アンタゴニストに対するアトピー性皮膚炎の治療応答を予測する方法
EP2021016B1 (en) Cxcl-13 antagonists and tnf-alpha antagonists for use in a combination therapy
PT2423230E (pt) Membro de ligação para o recetor de gm-csf
KR101681331B1 (ko) 치료를 위한 ｇｍ-ｃｓｆ 및 ｉｌ-17의 억제제
JP2005512507A6 (ja) 抗炎症剤としてのｈｍｇフラグメントの使用
de Boer Perspectives for cytokine antagonist therapy in COPD
オオグシフミタカ et al. Autoantibodies to IL-1α in sera from rapidly progressive idiopathic pulmonary fibrosis
US20070280936A1 (en) Method for treating psoriasis
JP2011502170A (ja) 変形性関節症疾患の治療又は予防のためのトール様受容体４拮抗物質の使用
WO2006057027A1 (en) Antigenic epitopes of interleukin-21, related antibodies and their use in medical field
Kajikawa et al. Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1: cytokines that mediate leukocyte recruitment to the lungs
CA2682666A1 (en) Cxcl13 antagonists and their use for the treatment of inflammatory diseases
Kim et al. Proteinase 3-processed form of the recombinant IL-32 separate domain
CN118909123A (zh) 人源化抗人cd132单克隆抗体及其应用
Kang et al. Suppressive effect of non-anaphylactogenic anti-IgE antibody on the development of dextran sulfate sodium-induced colitis
JP4257946B2 (ja) 可溶化ヒトインターロイキン１８レセプターα，その測定方法，測定用キット及び医薬組成物
JP2009507511A (ja) 炎症を診断および治療するための組成物および方法
US9045559B2 (en) Method for screening inhibitors of interleukin-32 (IL-32)
US7754207B2 (en) Methods of treating pulmonary fibrosis